EPISODE · Sep 8, 2025 · 26 MIN
Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health
from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search
In this episode of Executive Insights for Life Sciences Innovators, we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics, about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences.Learn more at genecoda.com.This conversation was originally recorded and streamed on YouTube Live on February 7th, 2025.
What this episode covers
In this episode of Executive Insights for Life Sciences Innovators, we speak with Dr. Nathan Stasko, CEO of Vast Therapeutics, about the company’s journey with nitric oxide technology in respiratory therapeutics. Dr. Stasko shares the challenges of advancing novel drug delivery approaches, lessons learned in building a biotech startup, and his perspective on innovation in life sciences.Learn more at genecoda.com.This conversation was originally recorded and streamed on YouTube Live on February 7th, 2025.
NOW PLAYING
Dr. Nathan Stasko | CEO, Vast Therapeutics – Nitric Oxide Innovation in Respiratory Health
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m